Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 471

Similar articles for PubMed (Select 16416218)

1.

Clinical outcomes of eradication of Helicobacter pylori in nonulcer dyspepsia in a population with a high prevalence of infection: results of a 12-month randomized, double blind, placebo-controlled study.

Mazzoleni LE, Sander GB, Ott EA, Barros SG, Francesconi CF, Polanczyk CA, Wortmann AC, Theil AL, Fritscher LG, Rivero LF, Cartell A, Edelweiss MI, Uchôa DM, Prolla JC.

Dig Dis Sci. 2006 Jan;51(1):89-98.

PMID:
16416218
2.

Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?

Güliter S, Keleş H, Ozkurt ZN, Cengiz DU, Kolukisa E.

Turk J Gastroenterol. 2005 Mar;16(1):29-33.

PMID:
16252185
3.
4.

CagA status and Helicobacter pylori eradication among dyspeptic patients.

Magalhães AF, Carvalhaes A, Natan-Eisig J, Paraíso-Ferraz JG, Trevisan M, Zaterkaad S.

Gastroenterol Hepatol. 2005 Oct;28(8):441-4.

PMID:
16185577
5.

Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia.

Froehlich F, Gonvers JJ, Wietlisbach V, Burnand B, Hildebrand P, Schneider C, Saraga E, Beglinger C, Vader JP; Eradication in Dyspepsia (ERADYS) Study Group.

Am J Gastroenterol. 2001 Aug;96(8):2329-36.

PMID:
11513170
6.

Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.

Koskenpato J, Farkkilä M, Sipponen P.

Am J Gastroenterol. 2001 Oct;96(10):2866-72.

PMID:
11693319
7.

Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.

Blum AL, Talley NJ, O'Moráin C, van Zanten SV, Labenz J, Stolte M, Louw JA, Stubberöd A, Theodórs A, Sundin M, Bolling-Sternevald E, Junghard O.

N Engl J Med. 1998 Dec 24;339(26):1875-81.

8.
9.

Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.

Talley NJ, Vakil N, Ballard ED 2nd, Fennerty MB.

N Engl J Med. 1999 Oct 7;341(15):1106-11.

10.

A prospective trial of lansoprazole triple therapy for pediatric Helicobacter pylori infection.

Shashidhar H, Peters J, Lin CH, Rabah R, Thomas R, Tolia V.

J Pediatr Gastroenterol Nutr. 2000 Mar;30(3):276-82.

PMID:
10749411
11.

Efficacy of the eradication of Helicobacter pylori infection in patients with chronic urticaria. A placebo-controlled double blind study.

Gaig P, García-Ortega P, Enrique E, Papo M, Quer JC, Richard C.

Allergol Immunopathol (Madr). 2002 Sep-Oct;30(5):255-8.

PMID:
12396958
13.

Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial.

Ott EA, Mazzoleni LE, Edelweiss MI, Sander GB, Wortmann AC, Theil AL, Somm G, Cartell A, Rivero LF, Uchôa DM, Francesconi CF, Prolla JC.

Aliment Pharmacol Ther. 2005 May 15;21(10):1231-9.

14.

Helicobacter pylori eradication versus prokinetics in the treatment of functional dyspepsia: a randomized, double-blind study.

Ang TL, Fock KM, Teo EK, Chan YH, Ng TM, Chua TS, Tan JY.

J Gastroenterol. 2006 Jul;41(7):647-53.

PMID:
16933001
15.

Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia.

Malfertheiner P, MOssner J, Fischbach W, Layer P, Leodolter A, Stolte M, Demleitner K, Fuchs W.

Aliment Pharmacol Ther. 2003 Sep 15;18(6):615-25.

16.

The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis.

Kamada T, Haruma K, Hata J, Kusunoki H, Sasaki A, Ito M, Tanaka S, Yoshihara M.

Aliment Pharmacol Ther. 2003 Jul 15;18(2):245-52.

17.

Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study.

Demiray M, Gulten M, Manavoglu O, Evrensel T, Ulukaya E, Yerci O, Kanat O, Kurt E, Arslan M, Gonullu G, Demiray H, Gulten T, Memik F.

Hepatogastroenterology. 2004 Sep-Oct;51(59):1531-5.

PMID:
15362794
18.

[Effect of Helicobacter pylori eradication on patients with functional dyspepsia].

de Artaza Varasa T, Valle Muñoz J, Pérez-Grueso MJ, García Vela A, Martín Escobedo R, Rodríguez Merlo R, Cuena Boy R, Carrobles Jiménez JM.

Rev Esp Enferm Dig. 2008 Sep;100(9):532-9. Spanish.

19.

Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial.

Oderda G, Marinello D, Lerro P, Kuvidi M, de'Angelis GL, Ferzetti A, Cucchiara S, Franco MT, Romano C, Strisciuglio P, Pensabene L.

Helicobacter. 2004 Aug;9(4):293-301.

PMID:
15270743
20.

Effect of the mucolytic erdosteine on the success rate of PPI-based first-line triple therapy for Helicobacter pylori eradication: a prospective, double-blind, randomized, placebo-controlled study.

Abut E, Yaşar B, Güveli H, Bölükbaş C, Bölükbaş FF, Dalay AR, Kurdaş OO.

Scand J Gastroenterol. 2010 Jun;45(6):677-83. doi: 10.3109/00365521003702726.

PMID:
20334478
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk